menu search

Astrazeneca said u.s. fda has accepted for review its flumist self-administered flu vaccine

AstraZeneca PLC AZN, -1.22% AZN, +1.45% said Tuesday the U.S. Food and Drug Administration has accepted its application for approval of a self-adminis...

October 24, 2023, 7:21 am

Us fda accepts astrazeneca's self-administered flu vaccine for review

AstraZeneca said on Tuesday the U.S. Food and Drug Administration (FDA) has accepted for review the company's application seeking approval for patient...

October 24, 2023, 2:11 am

Cvs to pull cold medicines deemed ineffective by fda

CVS Health (CVS) announced on Thursday that it will begin to pull several common cold products after an advisory panel from the FDA ruled that the act...

October 22, 2023, 8:00 am

Tiziana life sciences: fda signs off on home-based protocol fo ms treatment

Regulators have granted approval for home-based self-administration of Intranasal Foralumab, a treatme...

October 18, 2023, 7:23 am

Tiziana life sciences reveals positive pet scan results with foralumab to treat ms patients

Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that a reduction in activated microglia, as seen in six-month Positron Emission Tomography (PET) s...

October 13, 2023, 8:34 am

Tiziana life sciences to present ms treatment at ectrims annual congress

Tiziana Life Sciences Ltd (NASDAQ:TLSA) has announced that a late breaking poster titled, "Treatment Of Six Non-Active Secondary Progressive MS With <...

October 11, 2023, 9:26 am

Ocugen mucosal vaccine candidate ocu500 selected by nih/niaid project nextgen for inclusion in clinical trials

NIAID is conducting early phase clinical trials on select next generation vaccine candidates with the intent to identify the most effective platforms ...

October 10, 2023, 10:30 am

Lyra therapeutics' nasal matrix in focus: sniffing out opportunity

Lyra Therapeutics' LYR-220 shows promise in addressing chronic rhinosinusitis, targeting a patient demographic that doesn't respond to current treatme...

October 9, 2023, 1:20 am

Global high-flow nasal cannula market size to surpass usd 18.65 billion growth by 2030, exhibit a cagr of 12.18%

[228 + Pages Report] According to a market research study published by Zion Market Research, the demand analysis of Global High-flow ...

September 30, 2023, 3:57 am

Tiziana life sciences initiates multi-center phase 2a clinical trial of intranasal foralumab for na-spms

Tiziana Life Sciences Ltd (NASDAQ:TLSA) said it has commenced site initiation for its lead intranasal ...

September 26, 2023, 8:16 am

Ars pharmaceuticals vs. aquestive therapeutics; neffy crl creates an opportunity for investing in both

Both ARS Pharmaceuticals and Aquestive Therapeutics are developing non-injectable epinephrine products for anaphylaxis, with potential to capture sign...

September 22, 2023, 7:18 pm

Why shares of ars pharmaceuticals are plummeting on wednesday

ARS Pharmaceutical is seeking the approval of Neffy, a nasal spray version of epinephrine. The FDA is s...

September 20, 2023, 12:42 pm

Ars pharma shares bomb on surprise fda rebuff

Shares of ARS Pharmaceuticals Inc plummeted 51% in premarket trading after the US Food and Drug Administration (FDA) unexpectedly declined to approve...

September 20, 2023, 8:42 am

Seelos therapeutics' stock slides 36% after trial of treatment for suicidal ideation has too few patients to meet endpoint

Seelos Therapeutics Inc.'s stock SEEL tumbled 36% in premarket trade Wednesday, after the company reported promising results from a trial of a treatme...

September 20, 2023, 7:46 am

Ars pharmaceuticals stock falls toward record selloff after fda issues surprise crl, requesting additional studies

Sharesof ARS Pharmaceuticals Inc. SPRY plunged 46.9% toward a 15-month low in premarket trading Wednesday, after the biopharmaceutical company said th...

September 20, 2023, 6:21 am

Fda issues complete response letter for neffy® (epinephrine nasal spray) new drug application with request for additional study

Company aligned with FDA in August 2023 on both physician labeling and post-market requirements, which included a repeat-dose study of neffy under all...

September 20, 2023, 2:49 am

Decongestant found in many cold, allergy medicines doesn't actually work, fda advisors say

In a unanimous vote, advisors said oral versions of phenylephrine – a nasal decongestant found in ver...

September 12, 2023, 12:48 pm

Tiziana life sciences highlights publication of promising intranasal foralumab in alzheimer's study results

Tiziana Life Sciences Ltd (NASDAQ:TLSA) said a study validating the mechanism of action of its drug candidate intra...

September 6, 2023, 9:33 am

Gsk's new drug application for nucala accepted for review in japan

GSK PLC (LSE:GSK, NYSE:GSK) has announced that Japanese authorities have accepted for review a supplementary new drug application (sNDA) for Nucala,...

September 1, 2023, 2:29 am

Walgreens (wba) otc narcan nasal spray to be available soon

Walgreens (WBA) is instructing Americans to administer this life-saving drug that, if given in time, can reverse the effects of an opioid overdose....

August 31, 2023, 2:17 pm


Search within

Pages Search Results: